u-PA expression in benign, borderline and malignant ovarian tumors

被引:0
|
作者
Kiziridou, AD
Toliou, T
Stefanou, D
Agnantis, N
机构
[1] Theagen Anticanc Inst thessaloniki, Dept Pathol, Thessaloniki 54007, Greece
[2] Univ Ioannina, Sch Med, Dept Pathol, Ioannina 45100, Greece
关键词
plasminogen activator; ovarian carcinoma; borderline tumors; immunohistochemistry;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The malignant potential of solid tumors is related to their ability to invade adjacent tissue and to metastasize. The plasminogen activation system is one of the critical factors in tumor progression since it is involved in tumor invasion and metastasis. This study was performed to examine the expression of u-PA in benign, borderline and malignant tumors of the ovary by immunohistochemical evaluation on formalin-fixed, paraffin-embedded specimens applying monoclonal antibody 3689 directed to the b-chain of u-PA. Normal epithelial cells of the ovary (n =5) showed no staining of u-PA but some stromal cells were slightly stained. Invasive carcinomas (n=16) and borderline tumors (n = 15) showed a moderate to strong diffuse cytoplasmic staining. Benign tumors (n=20) showed a variety of staining. The observation of randomly positive u-PA stromal cells is noteworthy. The percentage of u-PA-positive tumors was higher in carcinomas than in other tumors. There was no con-elation with other known risk factors of malignancy such as differentiation, stage or type of tumor, In conclusion there are noticeable differences in u-PA expression among ovarian tumors and u-PA increase in ovarian tumors can be attributed to an increased diffuse cytoplasmic content in the neoplastic epithelial cells.
引用
收藏
页码:985 / 990
页数:6
相关论文
共 50 条
  • [31] Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelial tumors
    Kalir, T
    Wang, BY
    Goldfischer, M
    Reder, E
    Demopoulos, R
    Cohen, CJ
    Burstein, DE
    [J]. LABORATORY INVESTIGATION, 2002, 82 (01) : 200A - 200A
  • [32] Fas and Fas ligand in cyst fluids, serum and tumors of patients with benign and (borderline) malignant ovarian tumors
    Arts, HJG
    De Jong, S
    Hollema, H
    Ten Hoor, KA
    De Vries, EGE
    Van Der Zee, AGJ
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (02) : 379 - 384
  • [33] Expression of urokinase type plasminogen activator (u-PA) and U-PA inhibitor (PAI-1) in lung cancers: Clinical significance
    Brambilla, E
    Robert, C
    Bolon, I
    Decaussin, M
    [J]. LABORATORY INVESTIGATION, 1999, 79 (01) : 181A - 181A
  • [34] Regulation of u-PA gene expression in human prostate cancer
    Evans, CP
    Stapp, EC
    Dall'Era, MA
    Juarez, J
    Yang, JC
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (03) : 390 - 395
  • [35] Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma
    De Petro, G
    Tavian, D
    Copeta, A
    Portolani, N
    Giulini, SM
    Barlati, S
    [J]. CANCER RESEARCH, 1998, 58 (10) : 2234 - 2239
  • [36] Platelet associated u-PA up-regulates u-PA synthesis by endothelial cells
    Camoin-Jau, L
    Pannell, R
    Anfosso, F
    Bardin, N
    Sabatier, F
    Sampol, J
    Gurewich, V
    Dignat-George, F
    [J]. THROMBOSIS AND HAEMOSTASIS, 2002, 88 (03) : 517 - 523
  • [37] Effect of Escherichia coli lipopolysaccharide on u-PA activity and u-PA and u-PAR RNA expression in a bovine mammary epithelial cell line
    Baldi, Antonella
    Pecorini, Chiara
    Rebucci, Raffaella
    Saccone, Francesca
    Cheli, Federica
    Miranda-Ribera, Alba
    Lecchi, Cristina
    Ceciliani, Fabrizio
    [J]. RESEARCH IN VETERINARY SCIENCE, 2012, 93 (02) : 758 - 762
  • [38] Comparative expression of caspases and annexin V in benign and malignant ovarian tumors
    Hassan, Hanaa Ali
    Salem, Mohamed Labib
    Gouida, Mona Samy
    El-Azab, Khalid Mohammed
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (05) : 1042 - 1048
  • [39] EXPRESSION OF CATHEPSIN-D IN BENIGN AND MALIGNANT OVARIAN-TUMORS
    KRISTEN, P
    KAMINSKI, C
    CAFFIER, H
    [J]. TUMORDIAGNOSTIK & THERAPIE, 1995, 16 (04) : 158 - 161
  • [40] Heparanase-2 Expression in Normal Ovarian Epithelium and in Benign and Malignant Ovarian Tumors
    de Moura, Joel Pereira, Jr.
    Nicolau, Sergio Mancini
    Stavale, Joao Norberto
    da Silva Pinhal, Maria Aparecida
    de Matos, Leandro Luongo
    Baracat, Edmund Chada
    de Lima, Geraldo Rodrigues
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (09) : 1494 - 1500